What is Union Biometrica?
Founded in 1998, Union Biometrica specializes in Large Particle Flow Cytometry, a niche yet vital segment of the life sciences industry. The company designs and manufactures advanced flow cytometers, such as the COPAS and BioSorter systems, which are engineered to handle large or fragile biological specimens that conventional equipment cannot process. These systems are instrumental in the automated analysis and gentle sorting of stem cells, cell clusters, and model organisms like zebrafish embryos and C. elegans. By enabling high-throughput experiments with superior speed, sensitivity, and reproducibility, Union Biometrica provides researchers with the quantitative tools necessary for breakthrough discoveries in biotechnology and developmental biology. With a robust operational footprint spanning North America and Europe, the company remains a cornerstone for laboratories requiring precision instrumentation for complex biological samples.
How much funding has Union Biometrica raised?
Union Biometrica has raised a total of $816K across 2 funding rounds:
Debt
$350K
Debt
$466K
Debt (2020): $350K with participation from PPP
Debt (2021): $466K led by PPP
Key Investors in Union Biometrica
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Union Biometrica?
With the recent influx of capital, Union Biometrica is well-positioned to accelerate its research and development initiatives, focusing on the next generation of flow cytometry technology. The strategic deployment of these funds will likely prioritize the expansion of their product portfolio and the enhancement of their global distribution network. As the demand for high-throughput, automated biological sorting continues to rise in the pharmaceutical and academic sectors, the company is poised to capture additional market share by refining its existing systems and exploring new applications for its proprietary technology. Future growth will be driven by a focus on operational efficiency and the continued integration of advanced data analytics into their existing hardware platforms, ensuring that Union Biometrica remains a leader in the evolving landscape of life science research tools.
See full Union Biometrica company page
